D
Dierenartsen Centrum Euroweg
● Website: dierenartsen.nl
Business Health Check
Free comprehensive assessment for Dierenartsen Centrum Euroweg
16
Critical
Financial Health0/100
Company Size0/100
Growth Potential0/100
Stability & Risk60/100
Data Completeness35/100
Monitor Dierenartsen Centrum Euroweg
Get real-time alerts when this company's health score changes. Track competitors, suppliers, and clients.
Try SCALA OS →
🔔 Get notified when this score changes
Free. No spam. Unsubscribe anytime.
💼
Manage this company in your CRM
Import into S.C.A.L.A. CRM with AI agent SARA. From €97/mo.
Risk Overview
● Revenue: No data
● Profitability: Unknown
● Status: active
Key People
Executive data not available. Get Enterprise Report →
Corporate Structure
Corporate group data requires LEI. Get Enterprise Report →
Ownership
Detailed ownership available in Get Enterprise Report →
Top Competitors
Companies in the same sector and revenue range
| Company | Revenue | Employees | Score |
|---|---|---|---|
| Dierenartsen Centrum Euroweg | N/A | N/A | N/A |
| stoel van klaveren bouwstoffen bv (part of crh plc) | > €1B | 1,000+ | 80 |
| owner at atl coatings | > €1B | 1,000+ | 80 |
| akzo nobel chemicals | > €1B | 1,000+ | 80 |
| hbm stadien- und sportstättenbau gmbh | > €1B | 1,000+ | 80 |
| rhenus office systems | > €1B | 1,000+ | 80 |
Certifications & Standards
No certifications on record. Claim this profile to add certifications (ISO 9001, ISO 14001, SOC 2, etc.).
Credit Worthiness
Fair
Acceptable financial standing
Latest News
Loading...
Company Details
| Address | Euroweg 8-I, 9351EN |
| Source | osm_geofabrik |
Website preview — dierenartsen.nl
Similar Companies in Leek
stoel van klaveren bouwstoffen bv (part of crh plc) €1.9B
owner at atl coatings €3.3B
akzo nobel chemicals €3.3B
hbm stadien- und sportstättenbau gmbh €3.0B
rhenus office systems €1.4B
bosch car service uk & ireland €1.4B
klipper linde €5.7B
akzonobel car refinishes €3.3B
royal bam group nv €3.0B
aon groep nederland bv €1.2B
stokvis tapes benelux bv €1.2B
bewust veilig-dag 2024 €1.1B